Recombinant SARS-CoV-2 Spike (Casirivimab Biosimilar) antibody

Catalog No. ABIN7795137

The Human Monoclonal anti-SARS-CoV-2 Spike (Casirivimab Biosimilar) antibody is suitable to detect SARS-CoV-2 Spike (Casirivimab Biosimilar) in samples from Human. It has been validated for FACS and in vivo.

Quick Overview for Recombinant SARS-CoV-2 Spike (Casirivimab Biosimilar) antibody (ABIN7795137)

Target: SARS-CoV-2 Spike (Casirivimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: Un-conjugated

Application: Flow Cytometry (FACS), In vivo Studies (in vivo)

Grade: Research Grade

Product Details

Expression System: Mammalian cells

Purpose: Casirivimab Biosimilar, SARS-CoV-2 Spike Monoclonal Antibody

Characteristics: What is casirivimab biosimilar research grade? Casirivimab is a human monoclonal antibody directed against the spike protein of SARS-CoV-2. Casirivimab is a human monoclonal antibody (IgG1κ isotype). Casirivimab biosimilar uses the same protein sequences as the therapeutic antibody casirivimab. Casirivimab/imdevimab is a combination medicine used for the treatment and prevention of COVID-19. It consists of two human monoclonal antibodies, casirivimab and imdevimab that must be mixed together and administered as an infusion or subcutaneous injection. The combination of two antibodies is intended to prevent mutational escape. Casirivimab and imdevimab bind distinct epitopes on the RBD with dissociation constants KD of 46 and 47 pM, respectively. Please contact us if you are interested in the anti-SARS-CoV-2 spike monoclonal antibody imdevimab biosimilar.

Purification: Protein A or G affinity column

Purity: >95 % by reducing SDS-PAGE

Endotoxin Level: < 1 EU per 1 mg of the protein by the LAL method

Isotype: IgG1, kappa

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: > 3 mg/mL

Storage: 4 °C,-20 °C

Storage Comment: Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.

Target Details

Target: SARS-CoV-2 Spike (Casirivimab Biosimilar)

Alternative Name: Casirivimab Biosimilar

Target Type: Biosimilar